Hallucinogenic mushrooms may hold the key to treating anxiety, depression in cancer patients

Researchers might be closing in on a far-out approach to treating anxiety and depression in cancer patients. Two new studies released Thursday indicate that just one dose of psilocybin, a substance found only in hallucinogenic mushrooms, could immediately cut anxiety and depression in cancer patients for as long as eight months.
Two separate trials, the results of which were both published in the Journal of Psychopharmacology, found side effects of the drug to be "minimal," and results to be apparent in about "about 80 percent" of patients, The New York Times reported. "In spite of their unique vulnerability and the mood disruption that the illness and contemplation of their death has prompted, these participants have the same kind of experiences, that are deeply meaningful, spiritually significant, and producing enduring positive changes in life and mood and behavior," said Professor Roland Griffiths, who led the study at the Johns Hopkins University School of Medicine.
Psilocybin, along with other hallucinogens, has been classified as a Schedule 1 drug in the U.S. for more than 40 years. Though these studies' findings were hailed as "the most profound to date in the medical use of psilocybin," scientists say much more research must be done.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
One great cookbook: ‘The Woks of Life’
The Week Recommends A family’s opinionated, reliable take on all kinds of Chinese cooking
-
Digital addiction: the compulsion to stay online
In depth What it is and how to stop it
-
Can Trump bully Netanyahu into Gaza peace?
Today's Big Question The Israeli leader was ‘strong-armed’ into new peace deal
-
Japan poised to get first woman prime minister
Speed Read The ruling Liberal Democratic Party elected former Economic Security Minister Sanae Takaichi
-
Israel and Hamas meet on hostages, Trump’s plan
Speed Read Hamas accepted the general terms of Trump’s 20-point plan, including the release of all remaining hostages
-
US tipped to help Kyiv strike Russian energy sites
Speed Read Trump has approved providing Ukraine with intelligence for missile strikes on Russian energy infrastructure
-
Netanyahu agrees to Trump’s new Gaza peace plan
Speed Read At President Trump's meeting with Israeli Prime Minister Benjamin Netanyahu, they agreed upon a plan to end Israel’s war in Gaza
-
Russia is ‘helping China’ prepare for an invasion of Taiwan
In the Spotlight Russia is reportedly allowing China access to military training
-
Moldova gives decisive win to pro-EU party
Speed Read The country is now on track to join the European Union within five years
-
Interpol arrests hundreds in Africa-wide sextortion crackdown
IN THE SPOTLIGHT A series of stings disrupts major cybercrime operations as law enforcement estimates millions in losses from schemes designed to prey on lonely users
-
UK, 3 Western allies recognize Palestinian state
Speed Read Britain, Canada, Australia and Portugal formally recognized the state of Palestine